首页 > 最新文献

Klinichna ta profilaktichna meditsina最新文献

英文 中文
ANGIOTENSIN II TYPE I RECEPTOR POLYMORPHISM (A1166C AT1R) AS A FACTOR COMPLICATING THE COURSE OF COVID-19 血管紧张素ii I型受体多态性(a1166c at1r)是COVID-19病程复杂化的一个因素
Pub Date : 2023-08-04 DOI: 10.31612/2616-4868.3(25).2023.01
A.I. Vatsenko, T. Koval
Intriduction: The acute respiratory disease COVID-19 continues to pose a threat to human health worldwide. Identifying new predictors of severe coronavirus disease is necessary to prevent new outbreaks and reduce mortality among the population. The aim of the study was to analyze the prevalence and impact of the angiotensin II type 1 receptor polymorphism (A1166C at1r) on the severity of COVID-19. Materials and methods: We conducted a case-control study involving 151 patients who were diagnosed with COVID-19 and were inpatients at the Municipal Clinical Institution "POKIL" of the OR and the Municipal Clinical Institution "3rd City Hospital of the OR" from April 2020 to March 2021. The diagnosis was made based on the examination of patients by polymerase chain reaction (PCR) and the detection of SARS-CoV-2 virus RNA in the nasopharyngeal scrapings. One of the three genotypes of the at1r gene (rs5186) was identified in each of the patients: AA, AC, and CC. The distribution of genotypes was as follows: AA - 58 people (38.4%), AC - 70 (46.4%), CC - 23 (15.2%). The group of healthy individuals had the following genotype distribution: AA - 42 people (51.2%), AC - 28 people (34.1%) and SS - 12 people (14.7%). In order to determine the impact of the at1r gene polymorphism on the course of COVID-19, patients (n=151) were divided into 2 groups depending on the carriage of the C allele. Results: The combined AS+CC genotype was significantly more common in the group with severe (p=0.011) and severe + critical (p=0.003) course compared to the control group. Patients with combined AC+CC genotype were significantly more likely to be hospitalized with moderate (p=0.016) and severe and critical disease (p=0.016). Patients with the combined AC+CC genotype were significantly more likely to require oxygen therapy (67.7%) compared to patients with the AA genotype (44.8%), p=0.005. They were more likely to be supported with a face mask - 49 (52.7%). Conclusions: the angiotensin II type 1 receptor polymorphism (A1166C at1r) is a factor influencing the severity of COVID-19. Patients with a combined AC+CC genotype are significantly more likely to have a severe course of the disease and require oxygen support.
急性呼吸道疾病COVID-19继续在全球范围内对人类健康构成威胁。确定严重冠状病毒疾病的新预测因子对于预防新的疫情和降低人群死亡率是必要的。本研究的目的是分析血管紧张素II型1受体多态性(A1166C at1r)的患病率及其对COVID-19严重程度的影响。材料与方法:我们对2020年4月至2021年3月在OR市临床机构“POKIL”和市临床机构“OR市第三医院”住院的诊断为COVID-19的151例患者进行了病例对照研究。采用聚合酶链反应(PCR)对患者进行检查,并在鼻咽刮擦物中检测SARS-CoV-2病毒RNA。at1r基因(rs5186)在AA、AC和CC 3种基因型中均有1种,基因型分布为AA - 58人(38.4%)、AC - 70人(46.4%)、CC - 23人(15.2%)。健康人群基因型分布为:AA - 42人(51.2%)、AC - 28人(34.1%)、SS - 12人(14.7%)。为了确定at1r基因多态性对COVID-19病程的影响,根据C等位基因的携带情况将患者(n=151)分为两组。结果:AS+CC联合基因型在重症组(p=0.011)和重症+危重组(p=0.003)明显高于对照组。AC+CC联合基因型患者以中度(p=0.016)、重度和危重型(p=0.016)住院的可能性显著增加。AC+CC联合基因型患者需要氧疗的可能性(67.7%)明显高于AA基因型患者(44.8%),p=0.005。他们更有可能得到口罩的支持- 49(52.7%)。结论:血管紧张素II型1受体多态性(A1166C at1r)是影响COVID-19严重程度的一个因素。合并AC+CC基因型的患者更有可能出现严重的病程并需要氧气支持。
{"title":"ANGIOTENSIN II TYPE I RECEPTOR POLYMORPHISM (A1166C AT1R) AS A FACTOR COMPLICATING THE COURSE OF COVID-19","authors":"A.I. Vatsenko, T. Koval","doi":"10.31612/2616-4868.3(25).2023.01","DOIUrl":"https://doi.org/10.31612/2616-4868.3(25).2023.01","url":null,"abstract":"Intriduction: The acute respiratory disease COVID-19 continues to pose a threat to human health worldwide. Identifying new predictors of severe coronavirus disease is necessary to prevent new outbreaks and reduce mortality among the population. \u0000The aim of the study was to analyze the prevalence and impact of the angiotensin II type 1 receptor polymorphism (A1166C at1r) on the severity of COVID-19. \u0000Materials and methods: We conducted a case-control study involving 151 patients who were diagnosed with COVID-19 and were inpatients at the Municipal Clinical Institution \"POKIL\" of the OR and the Municipal Clinical Institution \"3rd City Hospital of the OR\" from April 2020 to March 2021. The diagnosis was made based on the examination of patients by polymerase chain reaction (PCR) and the detection of SARS-CoV-2 virus RNA in the nasopharyngeal scrapings. One of the three genotypes of the at1r gene (rs5186) was identified in each of the patients: AA, AC, and CC. The distribution of genotypes was as follows: AA - 58 people (38.4%), AC - 70 (46.4%), CC - 23 (15.2%). \u0000The group of healthy individuals had the following genotype distribution: AA - 42 people (51.2%), AC - 28 people (34.1%) and SS - 12 people (14.7%). In order to determine the impact of the at1r gene polymorphism on the course of COVID-19, patients (n=151) were divided into 2 groups depending on the carriage of the C allele. \u0000Results: The combined AS+CC genotype was significantly more common in the group with severe (p=0.011) and severe + critical (p=0.003) course compared to the control group. Patients with combined AC+CC genotype were significantly more likely to be hospitalized with moderate (p=0.016) and severe and critical disease (p=0.016). Patients with the combined AC+CC genotype were significantly more likely to require oxygen therapy (67.7%) compared to patients with the AA genotype (44.8%), p=0.005. They were more likely to be supported with a face mask - 49 (52.7%). \u0000Conclusions: the angiotensin II type 1 receptor polymorphism (A1166C at1r) is a factor influencing the severity of COVID-19. Patients with a combined AC+CC genotype are significantly more likely to have a severe course of the disease and require oxygen support.","PeriodicalId":34164,"journal":{"name":"Klinichna ta profilaktichna meditsina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70042017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CLINICAL AND LABORATORY FEATURES OF THE COURSE OF CHRONIC VIRAL HEPATITIS B AND C IN CHILDREN OF PODILSKY REGION: POSSIBILITY FOR MODERN MONITORING 波德尔斯基地区儿童慢性乙型和丙型病毒性肝炎病程的临床和实验室特征:现代监测的可能性
Pub Date : 2023-08-04 DOI: 10.31612/2616-4868.3(25).2023.11
I. Nezgoda, Y. Demchyshyn
Introduction. In modern hepatology, a special place is occupied by chronic viral hepatitis, including B and C, because today they occupy the leading positions due to their high prevalence, the possibility of severe complications, and also they could lead to death in both adults and children. Specialists should have a comprehensive understanding of the clinical course and laboratory diagnosis of viral hepatitis to facilitate timely diagnosis and effective management of this condition. The aim: to evaluate the clinical and laboratory features of the course of chronic viral hepatitis B and C in children by determining patterns between parametric indexes characterizing the processes of liver fibrosis. Materials and methods. In the process of scientific research, 49 children were examined, including 29 children with diagnosed chronic viral hepatitis B and C (group I) and 20 almost healthy children (group II). The diagnoses of CHB and CHC were confirmed by the PCR method and specific markers detected by ELISA. All examined patients underwent anamnesis collection, general clinical examination, laboratory examination, calculation of CDS, Lok, GUCI, APRI, FIB-4 and "Fibrotest" diagnostic indexes. Statistical data analysis was carried out with "R-Studio" and "Statistica 10.0" software, using the methods of descriptive statistics, correlation analysis. Significance was considered significant at p<0.05. The study was conducted in compliance with the principles of the Declaration of Helsinki. Results. It was established that the levels of ALT, AST, GGT, ALP, indirect bilirubin, international normalized ratio (INR) were significantly higher in the examined patients of the I group. The level of the CDS index was significantly higher in the examined patients of the I group (5,97±0,30), compared with the patients of the II group (4,35±0,28) (p<0,001). A similar trend was noted with the Lok index and FIB-4 (p<0,001). The GUCI and APRI indices were significantly higher in patients of the I group (1,02±0,22; 0,73±0,04), compared to the examined patients of the II group (0,27±0,02; 0,23±0,02) (p<0,01). Conclusions. Implementation of non-invasive indices into clinical practice for the management of children with chronic hepatitis B and C will allow for dynamic monitoring of liver fibrogenesis processes.
介绍在现代肝病学中,包括乙型和丙型肝炎在内的慢性病毒性肝炎占据了一个特殊的位置,因为它们由于其高患病率、严重并发症的可能性以及可能导致成人和儿童死亡而占据了今天的主导地位。专家应全面了解病毒性肝炎的临床过程和实验室诊断,以便及时诊断和有效管理这种情况。目的:通过确定表征肝纤维化过程的参数指标之间的模式,评估儿童慢性乙型和丙型病毒性肝炎病程的临床和实验室特征。材料和方法。在科学研究过程中,对49名儿童进行了检查,其中29名儿童被诊断为慢性乙型和丙型病毒性肝炎(第一组),20名几乎健康的儿童(第二组)。通过PCR方法和ELISA检测特异性标志物,确认CHB和CHC的诊断。所有接受检查的患者都进行了回忆收集、一般临床检查、实验室检查、CDS、Lok、GUCI、APRI、FIB-4和“Fibrotest”诊断指标的计算。使用“R-Studio”和“Statistica 10.0”软件,采用描述性统计、相关分析等方法对数据进行统计分析。显著性在p<0.05时被认为是显著的。这项研究是根据《赫尔辛基宣言》的原则进行的。后果已确定I组检查患者的ALT、AST、GGT、ALP、间接胆红素、国际标准化比值(INR)水平显著升高。与II组患者(4,35±0,28)相比,I组患者的CDS指数水平显著更高(5,97±0,30)(p<0001)。Lok指数和FIB-4也有类似的趋势(p<0001)。I组患者的GUCI和APRI指数(1,02±0,22;0,73±0,04)显著高于II组的检查患者(0,27±0,02;0,23±0,02)(p<0.01)。结论。将非侵入性指标应用于慢性乙型和丙型肝炎儿童的临床实践,将有助于对肝纤维化过程进行动态监测。
{"title":"CLINICAL AND LABORATORY FEATURES OF THE COURSE OF CHRONIC VIRAL HEPATITIS B AND C IN CHILDREN OF PODILSKY REGION: POSSIBILITY FOR MODERN MONITORING","authors":"I. Nezgoda, Y. Demchyshyn","doi":"10.31612/2616-4868.3(25).2023.11","DOIUrl":"https://doi.org/10.31612/2616-4868.3(25).2023.11","url":null,"abstract":"Introduction. In modern hepatology, a special place is occupied by chronic viral hepatitis, including B and C, because today they occupy the leading positions due to their high prevalence, the possibility of severe complications, and also they could lead to death in both adults and children. Specialists should have a comprehensive understanding of the clinical course and laboratory diagnosis of viral hepatitis to facilitate timely diagnosis and effective management of this condition. \u0000The aim: to evaluate the clinical and laboratory features of the course of chronic viral hepatitis B and C in children by determining patterns between parametric indexes characterizing the processes of liver fibrosis. \u0000Materials and methods. In the process of scientific research, 49 children were examined, including 29 children with diagnosed chronic viral hepatitis B and C (group I) and 20 almost healthy children (group II). The diagnoses of CHB and CHC were confirmed by the PCR method and specific markers detected by ELISA. All examined patients underwent anamnesis collection, general clinical examination, laboratory examination, calculation of CDS, Lok, GUCI, APRI, FIB-4 and \"Fibrotest\" diagnostic indexes. Statistical data analysis was carried out with \"R-Studio\" and \"Statistica 10.0\" software, using the methods of descriptive statistics, correlation analysis. Significance was considered significant at p<0.05. The study was conducted in compliance with the principles of the Declaration of Helsinki. \u0000Results. It was established that the levels of ALT, AST, GGT, ALP, indirect bilirubin, international normalized ratio (INR) were significantly higher in the examined patients of the I group. The level of the CDS index was significantly higher in the examined patients of the I group (5,97±0,30), compared with the patients of the II group (4,35±0,28) (p<0,001). A similar trend was noted with the Lok index and FIB-4 (p<0,001). The GUCI and APRI indices were significantly higher in patients of the I group (1,02±0,22; 0,73±0,04), compared to the examined patients of the II group (0,27±0,02; 0,23±0,02) (p<0,01). \u0000Conclusions. Implementation of non-invasive indices into clinical practice for the management of children with chronic hepatitis B and C will allow for dynamic monitoring of liver fibrogenesis processes.","PeriodicalId":34164,"journal":{"name":"Klinichna ta profilaktichna meditsina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47712929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
INFLUENCE OF THE WAR ON THE ORGANIZATION OF MEDICAL ASSISTANCE FOR ONCOLOGICAL DISEASES 战争对肿瘤疾病医疗援助组织的影响
Pub Date : 2023-08-04 DOI: 10.31612/2616-4868.3(25).2023.12
A. Nabok, B. Palamar
The article discusses current issues of providing oncology medical care at the present time. Current legislation has been studied and modern approaches to the structure and features of the organization of providing medical care for malignant neoplasms during the war in Ukraine have been analyzed. Introduction. The war as a result of the Russian attack made it difficult for patients to access necessary medical services and medicines. The most problematic in the organization of cancer control in the regions are the timely detection of patients, adequate staging of the malignant process, registration of deaths, as well as the system of dispensary observation of cancer patients, without the establishment of which it is impossible to achieve success in increasing the survival rate of cancer patients. High levels of neglect of visual malignant neoplasms in many regions indicate that dental, gynecological and other services of the general hospital network of these regions do not take an active part in solving the problem of timely cancer diagnosis [1, 2, 4]. During the war, the Medical Guarantee Program continues to operate, and cancer patients can receive government-provided treatment free of charge. Guarantees cover medical care at every stage of treatment: diagnosis, chemotherapy and radiological treatment, support in outpatient or inpatient settings, surgery, rehabilitation, palliative care. A patient can receive medical assistance free of charge upon a doctor's referral [2, 11]. An analysis of the onco-epidemiological situation in Ukraine in recent years revealed a significant decrease in the number of both patients and deaths from cancer compared to previous years. The quantitative characteristics of morbidity were obviously affected by the epidemic of COVID-19 and the war in the country, which changed the organization of the diagnostic process and the patient's ability to get to a specialized oncology care facility [4]. The purpose of the work is to study the organization of medical care for oncological diseases during the period of martial law. Research materials and methods. An analysis of the legal framework was carried out. The following methods were used: content analysis, systematic approach and analysis.
本文就目前肿瘤医疗服务的现状进行了探讨。研究了目前的立法,并分析了乌克兰战争期间为恶性肿瘤提供医疗服务的组织的结构和特点的现代方法。介绍。俄罗斯攻击造成的战争使病人难以获得必要的医疗服务和药品。在组织地区的癌症控制中,最成问题的是及时发现患者、恶性过程的适当分期、死亡登记以及癌症患者的药房观察制度,没有建立这些制度,就不可能成功地提高癌症患者的存活率。许多地区对视觉恶性肿瘤的高度忽视表明,这些地区综合医院网络的牙科、妇科等服务没有积极参与解决癌症及时诊断的问题[1,2,4]。在战争期间,医疗保障计划继续运作,癌症患者可以免费接受政府提供的治疗。保障涵盖治疗各个阶段的医疗服务:诊断、化疗和放射治疗、门诊或住院支助、手术、康复、姑息治疗。病人可根据医生的推荐免费获得医疗援助[2,11]。对乌克兰近年来肿瘤流行病学情况的分析显示,与前几年相比,癌症患者和死亡人数都有显著减少。发病率的数量特征明显受到COVID-19流行和国内战争的影响,这改变了诊断过程的组织和患者获得专业肿瘤护理机构的能力[4]。这项工作的目的是研究戒严期间肿瘤疾病的医疗保健组织。研究材料和方法。对法律框架进行了分析。采用内容分析法、系统分析法和分析法。
{"title":"INFLUENCE OF THE WAR ON THE ORGANIZATION OF MEDICAL ASSISTANCE FOR ONCOLOGICAL DISEASES","authors":"A. Nabok, B. Palamar","doi":"10.31612/2616-4868.3(25).2023.12","DOIUrl":"https://doi.org/10.31612/2616-4868.3(25).2023.12","url":null,"abstract":"The article discusses current issues of providing oncology medical care at the present time. Current legislation has been studied and modern approaches to the structure and features of the organization of providing medical care for malignant neoplasms during the war in Ukraine have been analyzed. \u0000Introduction. The war as a result of the Russian attack made it difficult for patients to access necessary medical services and medicines. The most problematic in the organization of cancer control in the regions are the timely detection of patients, adequate staging of the malignant process, registration of deaths, as well as the system of dispensary observation of cancer patients, without the establishment of which it is impossible to achieve success in increasing the survival rate of cancer patients. High levels of neglect of visual malignant neoplasms in many regions indicate that dental, gynecological and other services of the general hospital network of these regions do not take an active part in solving the problem of timely cancer diagnosis [1, 2, 4]. \u0000During the war, the Medical Guarantee Program continues to operate, and cancer patients can receive government-provided treatment free of charge. Guarantees cover medical care at every stage of treatment: diagnosis, chemotherapy and radiological treatment, support in outpatient or inpatient settings, surgery, rehabilitation, palliative care. A patient can receive medical assistance free of charge upon a doctor's referral [2, 11]. \u0000An analysis of the onco-epidemiological situation in Ukraine in recent years revealed a significant decrease in the number of both patients and deaths from cancer compared to previous years. The quantitative characteristics of morbidity were obviously affected by the epidemic of COVID-19 and the war in the country, which changed the organization of the diagnostic process and the patient's ability to get to a specialized oncology care facility [4]. \u0000The purpose of the work is to study the organization of medical care for oncological diseases during the period of martial law. \u0000Research materials and methods. An analysis of the legal framework was carried out. The following methods were used: content analysis, systematic approach and analysis.","PeriodicalId":34164,"journal":{"name":"Klinichna ta profilaktichna meditsina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70041654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COMPARATIVE CHARACTERISTICS OF SUBSTANCE P CONCENTRATION AND NEUROPATHIC PAIN COMPONENT IN PATIENTS WITH ACUTE AND CHRONIC COURSES OF VERTEBROGENIC LUMBAR-SACRAL PAIN SYNDROMES 急性和慢性椎源性腰骶痛综合征患者p物质浓度和神经性疼痛成分的比较特征
Pub Date : 2023-08-04 DOI: 10.31612/2616-4868.3(25).2023.08
A. Payenok, A. Kulyk
The aim. The primary aim of this study is to assess the variance in substance P concentration, taking into account pain intensity and the presence of a neuropathic component, among patients experiencing acute and chronic vertebral lumbosacral pain syndromes. Materials. Measurement of substance P concentration in serum blood, evaluation of pain syndrome using the VAS scale, and assessment of pain according to the DN4 questionnaire were performed in patients receiving comprehensive treatment. A total of 125 patients were included in the study, comprising 65 patients with acute pain and 60 patients with chronic pain syndrome. Results. Pain ratings according to the Visual Analog Scale (VAS) among patients from the acute pain group was 7.15±1.07 on the VAS scale, while patients in the chronic pain group rated it at 6.09±0.96. On the 7th day of treatment, patients in the acute pain group reported a pain rating of 4.46±0.73, whereas those in the chronic pain group reported a rating of 4.22±0.97. The level of substance p(SP) in serum blood on the first day of treatment was 13.96±1.93 ng/mL in the acute pain group and 10.34±2.92 ng/mL in the chronic pain group. By the 7th day of treatment, the level decreased to 7.72±1.90 ng/mL in the acute pain group and 8.03±2.14 ng/mL in the chronic pain group. According to the DN4 questionnaire, neuropathic component was ascertained in 38% of patients with acute pain syndrome and 56% of participants with chronic pain. The average DN4 score in the acute pain group was 2.26±1.01, while in the chronic pain group, it was 4.53±1.02. In the group of patients with chronic pain syndrome and the presence of a neuropathic component, the level of SP was 10.89±1.78 ng/mL. In contrast, without the presence of a neuropathic component, it was 6.51±1.94 ng/mL. Conclusions. The trajectory of acute and chronic pain syndromes in patients with lumbosacral vertebral pain syndromes exhibits dissimilarities. Patients experiencing acute pain displayed a more favorable trend characterized by a reduction in pain intensity and a decrease in pain-related neurotransmitter concentration in the bloodstream.
的目标。本研究的主要目的是评估急性和慢性腰骶椎疼痛综合征患者在考虑疼痛强度和神经性成分的情况下P物质浓度的差异。材料。对接受综合治疗的患者进行血清血P物质浓度测定,采用VAS量表评价疼痛综合征,并根据DN4问卷对疼痛进行评估。研究共纳入125例患者,其中急性疼痛患者65例,慢性疼痛综合征患者60例。结果。急性疼痛组患者的VAS评分为7.15±1.07,慢性疼痛组患者的VAS评分为6.09±0.96。治疗第7天,急性疼痛组患者疼痛评分为4.46±0.73,慢性疼痛组患者疼痛评分为4.22±0.97。治疗第1天急性疼痛组和慢性疼痛组血清p物质(SP)水平分别为13.96±1.93 ng/mL和10.34±2.92 ng/mL。治疗第7天,急性疼痛组和慢性疼痛组分别降至7.72±1.90 ng/mL和8.03±2.14 ng/mL。根据DN4问卷,38%的急性疼痛综合征患者和56%的慢性疼痛患者确定了神经性成分。急性疼痛组平均DN4评分为2.26±1.01,慢性疼痛组平均DN4评分为4.53±1.02。慢性疼痛综合征伴神经性成分组SP水平为10.89±1.78 ng/mL。相比之下,没有神经病变成分的存在,它是6.51±1.94 ng/mL。结论。腰骶椎疼痛综合征患者的急性和慢性疼痛综合征表现出不同的轨迹。急性疼痛患者表现出更有利的趋势,其特征是疼痛强度降低,血流中与疼痛相关的神经递质浓度降低。
{"title":"COMPARATIVE CHARACTERISTICS OF SUBSTANCE P CONCENTRATION AND NEUROPATHIC PAIN COMPONENT IN PATIENTS WITH ACUTE AND CHRONIC COURSES OF VERTEBROGENIC LUMBAR-SACRAL PAIN SYNDROMES","authors":"A. Payenok, A. Kulyk","doi":"10.31612/2616-4868.3(25).2023.08","DOIUrl":"https://doi.org/10.31612/2616-4868.3(25).2023.08","url":null,"abstract":"The aim. The primary aim of this study is to assess the variance in substance P concentration, taking into account pain intensity and the presence of a neuropathic component, among patients experiencing acute and chronic vertebral lumbosacral pain syndromes. \u0000Materials. Measurement of substance P concentration in serum blood, evaluation of pain syndrome using the VAS scale, and assessment of pain according to the DN4 questionnaire were performed in patients receiving comprehensive treatment. A total of 125 patients were included in the study, comprising 65 patients with acute pain and 60 patients with chronic pain syndrome. \u0000Results. Pain ratings according to the Visual Analog Scale (VAS) among patients from the acute pain group was 7.15±1.07 on the VAS scale, while patients in the chronic pain group rated it at 6.09±0.96. On the 7th day of treatment, patients in the acute pain group reported a pain rating of 4.46±0.73, whereas those in the chronic pain group reported a rating of 4.22±0.97. The level of substance p(SP) in serum blood on the first day of treatment was 13.96±1.93 ng/mL in the acute pain group and 10.34±2.92 ng/mL in the chronic pain group. By the 7th day of treatment, the level decreased to 7.72±1.90 ng/mL in the acute pain group and 8.03±2.14 ng/mL in the chronic pain group. According to the DN4 questionnaire, neuropathic component was ascertained in 38% of patients with acute pain syndrome and 56% of participants with chronic pain. The average DN4 score in the acute pain group was 2.26±1.01, while in the chronic pain group, it was 4.53±1.02. In the group of patients with chronic pain syndrome and the presence of a neuropathic component, the level of SP was 10.89±1.78 ng/mL. In contrast, without the presence of a neuropathic component, it was 6.51±1.94 ng/mL. \u0000Conclusions. The trajectory of acute and chronic pain syndromes in patients with lumbosacral vertebral pain syndromes exhibits dissimilarities. Patients experiencing acute pain displayed a more favorable trend characterized by a reduction in pain intensity and a decrease in pain-related neurotransmitter concentration in the bloodstream.","PeriodicalId":34164,"journal":{"name":"Klinichna ta profilaktichna meditsina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70041585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RESULTS OF ANTIFIBROTIC THERAPY IN PATIENTS WITH CHRONIC HEPATITIS B+C 慢性B+C型肝炎患者的抗纤维化治疗效果
Pub Date : 2023-08-04 DOI: 10.31612/2616-4868.3(25).2023.06
K. Usychenko
Modern antiviral therapy regimens for patients with chronic viral hepatitis aim to achieve either long-term suppression of pathogen replication (e.g., nucleoside analogs in chronic hepatitis B) or complete elimination of the virus (such as direct-acting antiviral drugs in chronic hepatitis C). However, antiviral agents do not have a significant impact on the complete restoration of biochemical processes or the prevention of further progression of morphological changes in the liver. These limitations emphasize the ongoing need for new therapeutic strategies that target the processes of fibrogenesis. The aim of the work is to assess the possibility of the effect of the drug "Bicyclol" on fibrotic changes in patients with chronic hepatitis B+C using a non-invasive scale of the rate of fibrosis. Materials and methods An analysis of the dynamics of 62 patients with chronic hepatitis B and C (HCV+C) was conducted. All patients received long-term antiviral therapy consisting of pegylated interferon for 48 weeks. In the main group (Group I), patients with chronic hepatitis B and C were prescribed the drug "Bicyclol" after completing antiviral treatment with interferon. The control group (Group II) followed the principles of proper nutrition and took traditional hepatoprotectors. Based on the identified correlations, a non-invasive scale was proposed to assess the individual risk of liver fibrosis progression. Research results Against the background of the use of an antiviral treatment regimen, the normalization of cytolysis indicators was observed in most patients with CHB+C, but in some patients it was short-lived. Treatment with the drug "Bicyclol" contributed to a further decrease in cytolysis indicators, in the vast majority of patients with CHB+C, the activity of ALT and AST reached the upper limit of the norm. In patients with CHB+C who received only basic treatment without an antifibrotic component, a tendency to maintain an elevated level of transaminases was observed. Conclusions. Thus, the use of the hepatoprotector "Bicyclol" for 12 months ensures a decrease in cytolysis in the liver, is accompanied by a decrease in the severity of fibrosis, and in some patients - its reverse development. The use of the proposed prognostic scale makes it possible to assess the need for early appointment of antifibrotic therapy.
针对慢性病毒性肝炎患者的现代抗病毒治疗方案旨在实现病原体复制的长期抑制(例如慢性乙型肝炎中的核苷类似物)或病毒的完全消除(例如慢性丙型肝炎中的直接作用抗病毒药物)。然而,抗病毒药物对完全恢复生化过程或防止肝脏形态学变化的进一步发展没有显著影响。这些局限性强调了对针对纤维形成过程的新治疗策略的持续需求。这项工作的目的是使用非侵入性纤维化率量表来评估药物“双环醇”对慢性乙型+丙型肝炎患者纤维化变化的影响的可能性。材料与方法对62例慢性乙型和丙型肝炎(HCV+C)患者进行动态分析。所有患者均接受由聚乙二醇干扰素组成的长期抗病毒治疗48周。在主要组(I组)中,慢性乙型和丙型肝炎患者在完成干扰素抗病毒治疗后服用药物“双环醇”。对照组(Ⅱ组)遵循适当营养原则,服用传统护肝药。基于已确定的相关性,提出了一种非侵入性量表来评估肝纤维化进展的个体风险。研究结果在使用抗病毒治疗方案的背景下,在大多数CHB+C患者中观察到细胞溶解指标的正常化,但在一些患者中,这是短暂的。药物“双环醇”的治疗有助于细胞溶解指标的进一步降低,在绝大多数CHB+C患者中,ALT和AST的活性达到了正常值的上限。在仅接受不含抗纤维化成分的基础治疗的CHB+C患者中,观察到转氨酶水平升高的趋势。结论。因此,使用护肝剂“双环醇”12个月可确保肝脏细胞溶解减少,同时降低纤维化的严重程度,在某些患者中,纤维化的发展也会逆转。使用所提出的预后量表可以评估早期预约抗纤维化治疗的必要性。
{"title":"RESULTS OF ANTIFIBROTIC THERAPY IN PATIENTS WITH CHRONIC HEPATITIS B+C","authors":"K. Usychenko","doi":"10.31612/2616-4868.3(25).2023.06","DOIUrl":"https://doi.org/10.31612/2616-4868.3(25).2023.06","url":null,"abstract":"Modern antiviral therapy regimens for patients with chronic viral hepatitis aim to achieve either long-term suppression of pathogen replication (e.g., nucleoside analogs in chronic hepatitis B) or complete elimination of the virus (such as direct-acting antiviral drugs in chronic hepatitis C). However, antiviral agents do not have a significant impact on the complete restoration of biochemical processes or the prevention of further progression of morphological changes in the liver. These limitations emphasize the ongoing need for new therapeutic strategies that target the processes of fibrogenesis. \u0000The aim of the work is to assess the possibility of the effect of the drug \"Bicyclol\" on fibrotic changes in patients with chronic hepatitis B+C using a non-invasive scale of the rate of fibrosis. \u0000Materials and methods \u0000An analysis of the dynamics of 62 patients with chronic hepatitis B and C (HCV+C) was conducted. All patients received long-term antiviral therapy consisting of pegylated interferon for 48 weeks. In the main group (Group I), patients with chronic hepatitis B and C were prescribed the drug \"Bicyclol\" after completing antiviral treatment with interferon. The control group (Group II) followed the principles of proper nutrition and took traditional hepatoprotectors. Based on the identified correlations, a non-invasive scale was proposed to assess the individual risk of liver fibrosis progression. \u0000Research results \u0000Against the background of the use of an antiviral treatment regimen, the normalization of cytolysis indicators was observed in most patients with CHB+C, but in some patients it was short-lived. Treatment with the drug \"Bicyclol\" contributed to a further decrease in cytolysis indicators, in the vast majority of patients with CHB+C, the activity of ALT and AST reached the upper limit of the norm. In patients with CHB+C who received only basic treatment without an antifibrotic component, a tendency to maintain an elevated level of transaminases was observed. \u0000Conclusions. \u0000Thus, the use of the hepatoprotector \"Bicyclol\" for 12 months ensures a decrease in cytolysis in the liver, is accompanied by a decrease in the severity of fibrosis, and in some patients - its reverse development. The use of the proposed prognostic scale makes it possible to assess the need for early appointment of antifibrotic therapy.","PeriodicalId":34164,"journal":{"name":"Klinichna ta profilaktichna meditsina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47049924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CHRONIC CEREBRAL ISCHEMIA. MODERN VIEW OF THE PROBLEM 慢性脑缺血。这个问题的现代观点
Pub Date : 2023-08-04 DOI: 10.31612/2616-4868.3(25).2023.14
T. Cherniy, V. Cherniy, D.V. Svitlytska
Introduction. Chronic cerebral ischemia (CCI) is considered a syndrome that develops as a result of a slowly progressive reduction in cerebral blood flow. This reduction occurs due to the gradual accumulation of ischemic and secondary degenerative changes in the brain, which are caused by repeated ischemic episodes resulting from the development of atherosclerosis and arterial hypertension. These changes lead to impairment of brain functions, manifested by progressive neurological, neuropsychological, and mental disorders. The aim. To analyze the problems of pathogenesis, diagnosis, and treatment of CCI from the sources of modern literature in order to optimize the treatment of this group of patients.  Materials and methods. Bibliosemantic, comparative and method of system analysis.  Results. The pathogenetic mechanisms underlying CCI remain controversial due to the heterogeneity of causes and the complexity of the neuropathology associated with the disease. However, one common reason that can be named is dysregulation of cerebral blood flow, that results in chronic cerebral hypoperfusion, which can lead to the development of vascular cognitive impairment and dementia. Detection of biological markers in the patients' blood in combination with neuropsychological testing, neurophysiological (CEP P300, EEG) and neuroimaging (CT, MRI, Doppler Ultrasound of the head and neck) methods, which confirms the morphological substrate of vascular disease (leukoareosis, focal changes, multi-infarct condition, cerebral atrophy) and provides the possibility of choosing an effective pathogenetically-justified treatment. Conclusions. The rating of effectiveness of treatment in CCI is complicated considering difficulties in the selection of the efficiency criteria due to the significant differences in the methodology and research formats, as well as problem of a significant medication-related burden in the case of comorbidities. In this regard, the main direction in therapy is combined neuroprotection, which allows to optimize the possibilities of this strategy and to increase its clinical significance in angioneurology.
介绍。慢性脑缺血(CCI)被认为是一种由于脑血流缓慢进行性减少而发展的综合征。这种减少是由于脑缺血和继发性退行性变化的逐渐积累,这些变化是由动脉粥样硬化和动脉高血压的发展引起的反复缺血发作引起的。这些变化导致脑功能受损,表现为进行性神经学、神经心理学和精神障碍。的目标。结合现代文献资料,分析CCI的发病机制、诊断及治疗等方面存在的问题,以优化该类患者的治疗。材料和方法。文献语义学、比较学和系统分析方法。结果。由于病因的异质性和与该疾病相关的神经病理学的复杂性,CCI的发病机制仍然存在争议。然而,一个常见的原因是脑血流失调,导致慢性脑灌注不足,这可能导致血管性认知障碍和痴呆的发展。结合神经心理学、神经生理学(CEP P300、脑电图)和神经影像学(CT、MRI、头颈部多普勒超声)等方法检测患者血液中的生物标志物,确定血管疾病(白质疏松、局灶性改变、多发梗死、脑萎缩)的形态学基础,为选择有效的病因合理的治疗方法提供可能。结论。CCI治疗有效性的评估是复杂的,考虑到由于方法和研究形式的显着差异而在选择效率标准方面存在困难,以及在合并症的情况下存在显着的药物相关负担问题。在这方面,治疗的主要方向是联合神经保护,这可以优化该策略的可能性,并增加其在血管神经学中的临床意义。
{"title":"CHRONIC CEREBRAL ISCHEMIA. MODERN VIEW OF THE PROBLEM","authors":"T. Cherniy, V. Cherniy, D.V. Svitlytska","doi":"10.31612/2616-4868.3(25).2023.14","DOIUrl":"https://doi.org/10.31612/2616-4868.3(25).2023.14","url":null,"abstract":"Introduction. Chronic cerebral ischemia (CCI) is considered a syndrome that develops as a result of a slowly progressive reduction in cerebral blood flow. This reduction occurs due to the gradual accumulation of ischemic and secondary degenerative changes in the brain, which are caused by repeated ischemic episodes resulting from the development of atherosclerosis and arterial hypertension. These changes lead to impairment of brain functions, manifested by progressive neurological, neuropsychological, and mental disorders. \u0000The aim. To analyze the problems of pathogenesis, diagnosis, and treatment of CCI from the sources of modern literature in order to optimize the treatment of this group of patients. \u0000 Materials and methods. Bibliosemantic, comparative and method of system analysis. \u0000 Results. The pathogenetic mechanisms underlying CCI remain controversial due to the heterogeneity of causes and the complexity of the neuropathology associated with the disease. However, one common reason that can be named is dysregulation of cerebral blood flow, that results in chronic cerebral hypoperfusion, which can lead to the development of vascular cognitive impairment and dementia. Detection of biological markers in the patients' blood in combination with neuropsychological testing, neurophysiological (CEP P300, EEG) and neuroimaging (CT, MRI, Doppler Ultrasound of the head and neck) methods, which confirms the morphological substrate of vascular disease (leukoareosis, focal changes, multi-infarct condition, cerebral atrophy) and provides the possibility of choosing an effective pathogenetically-justified treatment. \u0000Conclusions. The rating of effectiveness of treatment in CCI is complicated considering difficulties in the selection of the efficiency criteria due to the significant differences in the methodology and research formats, as well as problem of a significant medication-related burden in the case of comorbidities. In this regard, the main direction in therapy is combined neuroprotection, which allows to optimize the possibilities of this strategy and to increase its clinical significance in angioneurology.","PeriodicalId":34164,"journal":{"name":"Klinichna ta profilaktichna meditsina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48640023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The psychological safety of specialists involved in the organization and provision of psychological assistance in war conditions 在战争条件下参与组织和提供心理援助的专家的心理安全
Pub Date : 2023-08-04 DOI: 10.31612/2616-4868.3(25).2023.09
N.G. Pylypenko
The aim. To provide an analysis of the theoretical foundations and practical approaches to addressing the issue of psychological safety for specialists involved in the organization and provision of psychological assistance in war conditions. Materials and methods. The research employed the bibliographic method, method of analysis, and synthesis of scientific materials from academic sources. Results and discussion. A detailed analysis of several scientific studies revealed that among the main prerequisites for the emergence of emotional burnout in helping professionals, two directions are traditionally identified: the characteristics of professional activities and the psychological characteristics of the specialist. In the context of the question about the psychological changes that can occur in professionals during their professional activities, we have examined the phenomenon of secondary trauma or secondary traumatic stress, which refers to the trauma experienced by a professional while providing psychological assistance. In the literature on crisis psychology, the phenomenon of burnout is often equated with the phenomenon of secondary trauma due to the following reasons: 1) both states tend to accumulate over time, and 2) they have similar consequences (insomnia, depressed mood, impaired communication with social environment and family).However, a detailed analysis of these phenomena indicates the presence of differences, primarily in the characteristics of their emergence. Conclusion. The main safety rules for assisting specialists, compliance with which is necessary to maintain their professional well-being, include: awareness of one's abilities and the limits of one's competence;having an understanding of one's vulnerabilities and assessing one's capabilities and risks when working with cases that involve heightened emotional sensitivity; tracking changes in one's emotional and physical state, as well as changes in behavior; seeking help from superiors when needed;when dealing with challenging crisis events and their aftermath, working better in pairs with colleagues. This is necessary for maintaining emotional balance for each specialist working in a pair and for the ability to rely on each other during consultations or group psychological work;participating periodically in supervision groups or receiving supervision.Following these rules is essential for preserving the emotional well-being of each specialist and enables them to rely on support systems such as working in pairs and seeking supervision or consultation when needed.
的目标。为参与组织和提供战争条件下心理援助的专家提供解决心理安全问题的理论基础和实践方法分析。材料和方法。本研究采用书目法、分析法和综合学术资料的方法。结果和讨论。对几项科学研究的详细分析表明,在帮助专业人员出现情绪倦怠的主要先决条件中,传统上认为有两个方向:专业活动的特征和专家的心理特征。在关于专业人员在其专业活动中可能发生的心理变化的问题的背景下,我们研究了继发性创伤或继发性创伤应激现象,这是指专业人员在提供心理援助时所经历的创伤。在危机心理学的文献中,倦怠现象往往等同于继发性创伤现象,原因如下:1)两种状态往往会随着时间的推移而积累,2)两者的后果相似(失眠、情绪低落、与社会环境和家庭沟通障碍)。然而,对这些现象的详细分析表明存在差异,主要是它们出现的特征。结论。协助专家的主要安全规则是维持他们的专业健康所必须遵守的,包括:意识到自己的能力和能力的局限性;了解自己的弱点,并在处理涉及高度情绪敏感的案件时评估自己的能力和风险;跟踪一个人的情绪和身体状态的变化,以及行为的变化;在需要时向上级寻求帮助;在处理具有挑战性的危机事件及其后果时,更好地与同事合作。这对于保持每个专家的情感平衡是必要的,对于在咨询或小组心理工作中相互依赖的能力是必要的,定期参加监督小组或接受监督。遵循这些规则对于保持每个专家的情感健康至关重要,并使他们能够依靠支持系统,例如结对工作,并在需要时寻求监督或咨询。
{"title":"The psychological safety of specialists involved in the organization and provision of psychological assistance in war conditions","authors":"N.G. Pylypenko","doi":"10.31612/2616-4868.3(25).2023.09","DOIUrl":"https://doi.org/10.31612/2616-4868.3(25).2023.09","url":null,"abstract":"The aim. To provide an analysis of the theoretical foundations and practical approaches to addressing the issue of psychological safety for specialists involved in the organization and provision of psychological assistance in war conditions. \u0000Materials and methods. The research employed the bibliographic method, method of analysis, and synthesis of scientific materials from academic sources. \u0000Results and discussion. A detailed analysis of several scientific studies revealed that among the main prerequisites for the emergence of emotional burnout in helping professionals, two directions are traditionally identified: the characteristics of professional activities and the psychological characteristics of the specialist. \u0000In the context of the question about the psychological changes that can occur in professionals during their professional activities, we have examined the phenomenon of secondary trauma or secondary traumatic stress, which refers to the trauma experienced by a professional while providing psychological assistance. In the literature on crisis psychology, the phenomenon of burnout is often equated with the phenomenon of secondary trauma due to the following reasons: 1) both states tend to accumulate over time, and 2) they have similar consequences (insomnia, depressed mood, impaired communication with social environment and family).However, a detailed analysis of these phenomena indicates the presence of differences, primarily in the characteristics of their emergence. \u0000Conclusion. \u0000The main safety rules for assisting specialists, compliance with which is necessary to maintain their professional well-being, include: awareness of one's abilities and the limits of one's competence;having an understanding of one's vulnerabilities and assessing one's capabilities and risks when working with cases that involve heightened emotional sensitivity; tracking changes in one's emotional and physical state, as well as changes in behavior; seeking help from superiors when needed;when dealing with challenging crisis events and their aftermath, working better in pairs with colleagues. This is necessary for maintaining emotional balance for each specialist working in a pair and for the ability to rely on each other during consultations or group psychological work;participating periodically in supervision groups or receiving supervision.Following these rules is essential for preserving the emotional well-being of each specialist and enables them to rely on support systems such as working in pairs and seeking supervision or consultation when needed.","PeriodicalId":34164,"journal":{"name":"Klinichna ta profilaktichna meditsina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70041638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE RELATIONSHIP BETWEEN THE ANATOMY FEATURES OF THE STRUCTURES OF THE PHARYNX AND THE DEVELOPMENT OF OBSTRUCTIVE SLEEP APNOEA SYNDROME IN ADULTS. 成人咽部结构解剖特征与阻塞性睡眠呼吸暂停综合征发生的关系。
Pub Date : 2023-08-04 DOI: 10.31612/2616-4868.3(25).2023.04
Yu. G. Shevchuk, Y. Dieieva
The aim. To assess the correlation between subjective measurements and objective volume of palatine tonsils in adults, and to test the effect of oropharyngeal anatomy, body mass index, age, and OSA severity on actual tonsil volume. In addition, we evaluated the effect of tonsil size on the development of OSA in adults. Materials and methods. A prospective study of 130 patients with rhonchopathy and obstructive sleep apnea syndrome was conducted. Patients underwent a physical examination, nocturnal polysomnography, Epworth Sleepiness Scale, body mass index (BMI, kg/m²), and a subjective assessment of snoring on an analog scale from 1 (not important) to 10 (worst possible). Results: pharyngeal tissues are also found to be proportional to body size in both patients with rhonchopathy and patients with OSA, which indicates a secondary role of anatomy in the pathogenesis of OSA development. Tonsil volume (p = 0.053) tended to correlate with the degree of severity OSA There were no significant differences in the mean apnea-hypopnea index (AHI) between patients with grade I (30.5), II (29.6), or III (38.2) tonsil hypertrophy. Patients with grade IV tonsil hypertrophy had a higher AHI (mean 103.2) than patients with grade I (p = 0.01), II (p = 0.01) or III (p = 0.03) hypertrophy. Conclusions: In adult patients with rhonchopathy and OSA, there is a reliable correlation between the clinical degree of tonsil hypertrophy and the objective volume of the tonsils. Possible changes in pharyngeal geometry associated with OSA do not affect the clinical ability to determine tonsil volume. Although tonsil volume correlates with AHI, clinically only grade IV tonsils are predictive of severe OSA. Pharyngeal tissue volume likely reflects body mass index rather than OSA.
的目标。评估成人腭扁桃体主观测量值与客观体积之间的相关性,并检验口咽解剖结构、体重指数、年龄和OSA严重程度对实际扁桃体体积的影响。此外,我们评估了扁桃体大小对成人阻塞性睡眠呼吸暂停发展的影响。材料和方法。对130例鼻窦病合并阻塞性睡眠呼吸暂停综合征患者进行前瞻性研究。患者接受体格检查、夜间多导睡眠描记仪、Epworth嗜睡量表、体重指数(BMI, kg/m²),并对打鼾进行1(不重要)至10(最严重)的主观评估。结果:鼻chopath病患者和OSA患者的咽组织也与体型成正比,这表明解剖结构在OSA发病机制中起次要作用。扁桃体体积(p = 0.053)倾向于与OSA严重程度相关。扁桃体肥大I级(30.5)、II级(29.6)和III级(38.2)患者的平均呼吸暂停低通气指数(AHI)无显著差异。IV级扁桃体肥大患者的AHI(平均103.2)高于I级(p = 0.01)、II级(p = 0.01)和III级(p = 0.03)肥大患者。结论:成年鼻病合并OSA患者扁桃体肥大的临床程度与扁桃体客观体积之间存在可靠的相关性。与OSA相关的咽部形状可能的改变不影响临床确定扁桃体体积的能力。虽然扁桃体体积与AHI相关,但临床上只有IV级扁桃体可预测严重的OSA。咽部组织体积可能反映身体质量指数而非OSA。
{"title":"THE RELATIONSHIP BETWEEN THE ANATOMY FEATURES OF THE STRUCTURES OF THE PHARYNX AND THE DEVELOPMENT OF OBSTRUCTIVE SLEEP APNOEA SYNDROME IN ADULTS.","authors":"Yu. G. Shevchuk, Y. Dieieva","doi":"10.31612/2616-4868.3(25).2023.04","DOIUrl":"https://doi.org/10.31612/2616-4868.3(25).2023.04","url":null,"abstract":"The aim. To assess the correlation between subjective measurements and objective volume of palatine tonsils in adults, and to test the effect of oropharyngeal anatomy, body mass index, age, and OSA severity on actual tonsil volume. In addition, we evaluated the effect of tonsil size on the development of OSA in adults. \u0000Materials and methods. A prospective study of 130 patients with rhonchopathy and obstructive sleep apnea syndrome was conducted. Patients underwent a physical examination, nocturnal polysomnography, Epworth Sleepiness Scale, body mass index (BMI, kg/m²), and a subjective assessment of snoring on an analog scale from 1 (not important) to 10 (worst possible). \u0000Results: pharyngeal tissues are also found to be proportional to body size in both patients with rhonchopathy and patients with OSA, which indicates a secondary role of anatomy in the pathogenesis of OSA development. Tonsil volume (p = 0.053) tended to correlate with the degree of severity OSA There were no significant differences in the mean apnea-hypopnea index (AHI) between patients with grade I (30.5), II (29.6), or III (38.2) tonsil hypertrophy. Patients with grade IV tonsil hypertrophy had a higher AHI (mean 103.2) than patients with grade I (p = 0.01), II (p = 0.01) or III (p = 0.03) hypertrophy. \u0000Conclusions: In adult patients with rhonchopathy and OSA, there is a reliable correlation between the clinical degree of tonsil hypertrophy and the objective volume of the tonsils. Possible changes in pharyngeal geometry associated with OSA do not affect the clinical ability to determine tonsil volume. Although tonsil volume correlates with AHI, clinically only grade IV tonsils are predictive of severe OSA. Pharyngeal tissue volume likely reflects body mass index rather than OSA.","PeriodicalId":34164,"journal":{"name":"Klinichna ta profilaktichna meditsina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70041571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EFFECTIVENESS OF HYALURONIC ACID INJECTIONS FOR PENIS ENLARGEMENT 透明质酸注射治疗阴茎增大的疗效
Pub Date : 2023-08-04 DOI: 10.31612/2616-4868.3(25).2023.15
O. Lytvak, V. Shaprynskyi, M.V. Markova
Introduction. Penis enlargement procedures are becoming increasingly common among men seeking to achieve more desirable aesthetics of their male organ. This paper reviews the literature to identify and analyze scientific studies on the use of hyaluronic acid in andrology to increase penis size. The aim. To evaluate the effectiveness and safety of the procedure of injectable penis enlargement using hyaluronic acid filler. Materials and Methods. We evaluated the current scientific evidence on all available injectable penis enlargement methods to assess their effectiveness. To achieve this goal, we conducted a systematic search for scientific medical information in English-language databases such as MEDLINE, Embase, AMED (Allied and Complementary Medicine) and HMIC (Health Management Information Consortium). We analyzed all articles that met the specified search parameters. In addition, we manually searched for relevant references in the found texts. Results. The analysis of the literature shows that the use of hyaluronic acid to increase penile girth is a fairly effective method. The injection of hyaluronic acid demonstrates safety and effectiveness in practice, contributing to an increase in penis circumference. The results of studies confirm the long-term success and satisfaction of patients using this method, in particular in long-term follow-up. Conclusions. The use of hyaluronic acid as a filler to increase the size of the penis is effective and has several advantages. This minimally invasive method has fast and noticeable effect, increasing both the volume and length of the penis. This can improve patients' self-esteem and quality of life in the area of sexual relations. In addition, the procedure does not require complex surgical interventions and has a minimal recovery time, because hyaluronic acid is injectable. In general, the use of hyaluronic acid for penis enlargement is a convenient and effective option that allows patients to quickly achieve the desired result and improve the quality of their intimate life.
介绍。阴茎增大手术在男性中变得越来越普遍,他们希望获得更理想的男性器官美学。本文综述了有关男科使用透明质酸增加阴茎尺寸的文献,并对其进行了科学分析。的目标。目的评价透明质酸填充剂注射阴茎增大术的有效性和安全性。材料与方法。我们评估了目前所有可用的注射阴茎增大方法的科学证据,以评估其有效性。为了实现这一目标,我们在MEDLINE、Embase、AMED(联合和补充医学)和HMIC(健康管理信息联盟)等英文数据库中进行了科学医学信息的系统搜索。我们分析了所有符合指定搜索参数的文章。此外,我们在找到的文本中手动搜索相关参考文献。结果。文献分析表明,使用透明质酸增加阴茎周长是一种相当有效的方法。注射透明质酸在实践中证明了安全性和有效性,有助于增加阴茎周长。研究结果证实了使用该方法的患者的长期成功和满意度,特别是在长期随访中。结论。使用透明质酸作为填充物来增加阴茎的大小是有效的,并且有几个优点。这种微创的方法,快速和显著的效果,增加阴茎的体积和长度。这可以提高患者在性关系方面的自尊和生活质量。此外,该过程不需要复杂的手术干预,恢复时间最短,因为透明质酸是可注射的。一般来说,使用透明质酸进行阴茎增大是一种方便有效的选择,可以让患者迅速达到预期的效果,提高他们的亲密生活质量。
{"title":"EFFECTIVENESS OF HYALURONIC ACID INJECTIONS FOR PENIS ENLARGEMENT","authors":"O. Lytvak, V. Shaprynskyi, M.V. Markova","doi":"10.31612/2616-4868.3(25).2023.15","DOIUrl":"https://doi.org/10.31612/2616-4868.3(25).2023.15","url":null,"abstract":"Introduction. Penis enlargement procedures are becoming increasingly common among men seeking to achieve more desirable aesthetics of their male organ. This paper reviews the literature to identify and analyze scientific studies on the use of hyaluronic acid in andrology to increase penis size. \u0000The aim. To evaluate the effectiveness and safety of the procedure of injectable penis enlargement using hyaluronic acid filler. \u0000Materials and Methods. We evaluated the current scientific evidence on all available injectable penis enlargement methods to assess their effectiveness. To achieve this goal, we conducted a systematic search for scientific medical information in English-language databases such as MEDLINE, Embase, AMED (Allied and Complementary Medicine) and HMIC (Health Management Information Consortium). We analyzed all articles that met the specified search parameters. In addition, we manually searched for relevant references in the found texts. \u0000Results. The analysis of the literature shows that the use of hyaluronic acid to increase penile girth is a fairly effective method. The injection of hyaluronic acid demonstrates safety and effectiveness in practice, contributing to an increase in penis circumference. The results of studies confirm the long-term success and satisfaction of patients using this method, in particular in long-term follow-up. \u0000Conclusions. The use of hyaluronic acid as a filler to increase the size of the penis is effective and has several advantages. This minimally invasive method has fast and noticeable effect, increasing both the volume and length of the penis. This can improve patients' self-esteem and quality of life in the area of sexual relations. In addition, the procedure does not require complex surgical interventions and has a minimal recovery time, because hyaluronic acid is injectable. In general, the use of hyaluronic acid for penis enlargement is a convenient and effective option that allows patients to quickly achieve the desired result and improve the quality of their intimate life.","PeriodicalId":34164,"journal":{"name":"Klinichna ta profilaktichna meditsina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70042342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ARTERIAL HYPERTENSION AND WAR, WHAT TO EXPECT? 高血压和战争,会发生什么?
Pub Date : 2023-08-04 DOI: 10.31612/2616-4868.3(25).2023.13
A. Kravchenko
The aim. To conduct an analysis and generalize scientific publications on the influence of war factors on morbidity indicators and the clinical course of arterial hypertension. Materials and methods. An analysis and generalization of scientific research and publications on the specifics of morbidity among military personnel and the population affected by war has been conducted. The following methods were utilized: a systematic approach, bibliosemantic analysis, and analytical methods. Results: The article focuses on the influence of war factors on the incidence rates and clinical course of arterial hypertension in both military personnel and the civilian population. Through a review of historical data and modern scientific sources, the study examines the long-term effects of stress factors on the development of hypertension, the peculiarities of its clinical manifestations, and the potential for predicting complications in individuals affected by military operations. The impact of nervous tension is particularly evident among frontline soldiers, as hypertension is observed, on average, 3-4 times more frequently compared to soldiers in the rear. The article emphasizes the clear correlation between the frequency of arterial hypertension in servicemen and the duration of their frontline deployment. Conclusion. Severe mental trauma and negative emotions, experienced by both military personnel and the civilian population during war, can not only contribute to an increased incidence of hypertension but also lead to a significant rise in the occurrence of the disease in young individuals, with severe clinical manifestations expected.
的目标。对战争因素对高血压发病指标及临床病程影响的科学文献进行分析和归纳。材料和方法。对军事人员和受战争影响的人口中发病率的具体情况的科学研究和出版物进行了分析和概括。采用了以下方法:系统方法、文献语义学分析和分析方法。结果:探讨战争因素对军人和平民高血压发病率及临床病程的影响。通过对历史数据和现代科学资料的回顾,本研究探讨了应激因素对高血压发展的长期影响,其临床表现的特殊性,以及预测军事行动影响个体并发症的潜力。神经紧张的影响在前线士兵中尤为明显,因为高血压的发生率平均是后方士兵的3-4倍。这篇文章强调了军人动脉高血压的频率与前线部署时间之间的明显相关性。结论。军事人员和平民在战争期间所经历的严重精神创伤和消极情绪,不仅会导致高血压发病率增加,而且还会导致年轻人患该病的人数大幅上升,预计会出现严重的临床表现。
{"title":"ARTERIAL HYPERTENSION AND WAR, WHAT TO EXPECT?","authors":"A. Kravchenko","doi":"10.31612/2616-4868.3(25).2023.13","DOIUrl":"https://doi.org/10.31612/2616-4868.3(25).2023.13","url":null,"abstract":"The aim. To conduct an analysis and generalize scientific publications on the influence of war factors on morbidity indicators and the clinical course of arterial hypertension. \u0000Materials and methods. An analysis and generalization of scientific research and publications on the specifics of morbidity among military personnel and the population affected by war has been conducted. The following methods were utilized: a systematic approach, bibliosemantic analysis, and analytical methods. \u0000Results: The article focuses on the influence of war factors on the incidence rates and clinical course of arterial hypertension in both military personnel and the civilian population. Through a review of historical data and modern scientific sources, the study examines the long-term effects of stress factors on the development of hypertension, the peculiarities of its clinical manifestations, and the potential for predicting complications in individuals affected by military operations. The impact of nervous tension is particularly evident among frontline soldiers, as hypertension is observed, on average, 3-4 times more frequently compared to soldiers in the rear. The article emphasizes the clear correlation between the frequency of arterial hypertension in servicemen and the duration of their frontline deployment. \u0000Conclusion. Severe mental trauma and negative emotions, experienced by both military personnel and the civilian population during war, can not only contribute to an increased incidence of hypertension but also lead to a significant rise in the occurrence of the disease in young individuals, with severe clinical manifestations expected.","PeriodicalId":34164,"journal":{"name":"Klinichna ta profilaktichna meditsina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70042330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Klinichna ta profilaktichna meditsina
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1